Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 334 results for "zydus cadila"

Cadila Healthcare posts 47% rise in Q1 profit

Cadila Healthcare posts 47% rise in Q1 profit

Ahmedabad : Ahmedabad-based pharmaceutical company Cadila Healthcare (also known as Zydus Cadila) posted a 47% rise in consolidated net profit at Rs.353 crore for the quarter ended June 2015, the company said on Wednesday. It had posted a net ..., 3 weeks ago
Zydus Cadila: A year of unparalleled growth Bio Spectrum Asia, 1 month ago

4 images for zydus cadila

Pharma Letter, 3 weeks ago
PR inside, 3 weeks ago, 1 month ago
Bio Spectrum Asia, 1 month ago
India Infoline

Zydus receives final approval for Amiloride Hcl tablets

Zydus Cadila has received the final approval from USFDA to market Amiloride Hydrochloride Tablets USP , 5 mg.
 Money Control3 weeks ago Cadila gets USFDA nod for Pyridostigmine Bromide tablets  Business Standard2 months ago Zydus Cadila gets approval for Pyridostigmine Bromide Tablets  India Infoline2 months ago

Cadila Healthcare gains after receiving market authorisation from USFDA for a medicine

Cadila Healthcare rose 1.29% to Rs 1,820 at 15:15 IST on BSE after the company said the Zydus group has received the market authorisation from the United States Food & Drug Administration to market Morphine Sulfate ER tablet. The company made announcement ...
 Business Standard2 months ago Cadila Health up 3%, Zydus to market pain killer drug in US  Money Control2 months ago Lupin, Cadila Health, Alembic Pharma up 1-3% on USFDA nods  Moneycontrol.com2 months ago Zydus receives market authorisation for Morphine Sulfate ER Tablets  MyIris2 months ago

Zydus gets USFDA nod to sell morphine sulfate tablets

Shares of Cadila Healthcare were trading at Rs 1,839 per scrip in mid-day trade, up 2.34% from previous close on the BSE.
 DNA2 months ago Zydus Gets US Regulator's Nod for Pain Reliever Tablets  NDTV Profit2 months ago Zydus gets USFDA nod for morphine sulfate tablets  Daily Excelsior.com2 months ago Pharma companies unruffled by USFDA fee hike; want faster drug approvals instead  Business Today India3 weeks ago

Zydus Cadila bets big on oncology

After having established a strong presence in cardiology, respiratory and other segments, pharma major Cadila Healthcare, popularly known as Zydus Cadila, is betting big on oncology and aims to become the number one in the segment by 2020.
 Times of India1 month ago

Zydus to use psychometric tests to assess staff performance, potential

MUMBAI: As Indian drugmakers struggle to keep up with growing demands of regulatory compliance and integrity within the organisation, Zydus Cadila has decided to use psychometric tests to assign roles that suit an employee's personality and not just the ...
 Economic Times3 weeks ago Top Pharma news of the day  India Infoline3 weeks ago
Ani News

Govt. can help private sector set up clinics, medical schools, colleges, diagnostic facilities

Aug 31, 5:35 pm New Delhi, Aug.31 ( ANI ): Minister of State for the Prime Minister Office, Dr. Jitendra Singh, on Monday suggested that the government could provide public facilities and other support to the private sector for setting up ...
 Ani News2 days ago Jitendra Singh to inaugurate FICCI HEAL 2015′  Siasat Daily3 days ago

Teva-Allergan deal may divest products worth $600 million

BY: Divya Rajagopal & Vikas Dandekar MUMBAI: As Israeli drugmaker Teva readies to acquire Allergan as part of its recent $40.5-billion deal, a large bounty of products is expected to be up for grabs for generic drugmakers. According to collated data, products ...
 Economic Times6 days ago

Hepatitis A - Pipeline Review, H1 2015

Research and Markets ( has announced the addition of the "" report to their offering. This report provides comprehensive information on the therapeutic development for Hepatitis A, ...
 Individual.com1 month ago Global Statin Market 2015-2019  Franklin Credit Management Corporation1 month ago Research and Markets: Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating  Yahoo! Finance UK and Ireland1 month ago Global Statin Market 2015-2019 with AstraZeneca, Merck, Novartis & Pfizer Dominating  Individual.com1 month ago

Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th

) - Pieris Pharmaceuticals, Inc . ( NASDAQ: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that it will conduct a conference call on Thursday, August 13 at 10:00 AM (EDT) to ...
 Marketplace1 month ago Pieris Pharmaceuticals, Inc. (PIRS: null) | Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock  OTC Markets1 month ago Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock  Fat Pitch Financials1 month ago PIERIS PHARMACEUTICALS : to Host Second Quarter 2015 Investor Call on August 13th  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus cadila
Get updated on latest news & your favorite topics right in your inbox!
More     Less